Concepedia

Kathy Holtz

KH

Statistics

Publications

4

Citations

218

H-Index

4

Active since

2006

Affiliations

MSM Protein Technologies (United States)(Current)

Kathy Holtz is an author at MSM Protein Technologies (United States) specializing in vaccination, immunization, and vaccinology.

Publications per year

2006–2016

4

Publications

4

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

Zhifeng Zhou, Penny Post, Richard Chubet et al. · Vaccine · 2006 · 94 citations · Full text

, , +14

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Barry C. Buckland, Robert Boulanger, Mireli Fino et al. · Vaccine · 2014 · 80 citations

, , +16

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant

Clifton E. McPherson, Richard Chubet, Kathy Holtz et al. · Methods in molecular biology · 2016 · 33 citations

, , +12

Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate

David G. Rhodes, Kathy Holtz, Pam Robinson et al. · Vaccine · 2015 · 11 citations · Full text

, , +5

1–4 of 4